Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-24 @ 11:54 PM
NCT ID:
NCT05421351
Eligibility Criteria:
Inclusion Criteria:
1 . Age 18-65 years 2. Either gender 3. Patients with ACLF (CANONIC definition) of any etiology with HE ≥grade 2 as per West-Haven Criteria
Exclusion Criteria:
1. Patients with structural brain lesions, stroke, diagnosed neurological disease or history of seizures and are on neuropsychiatric medications, like sedatives, antidepressants, or antiepileptic drugs.
2. Severe preexisting cardiopulmonary disease.
3. Patients with hepatocellular carcinoma or systemic malignancy.
4. Post liver transplant patients.
5. HIV/AIDS infection.
6. Patients who are having active COVID-19 infection.
7. Those who do not consent to participate in the study.
8. Those who have TIPS or Porto systemic surgical shunt in situ.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT05421351
Study Brief:
Protocol Section:
NCT05421351